Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 3/2000

01-05-2000

Cytotoxic T-Lymphocyte Responses Elicited to Wilms' Tumor Gene WT1 Product by DNA Vaccination

Authors: Akihiro Tsuboi, Yoshihiro Oka, Hiroyasu Ogawa, Olga A. Elisseeva, Hanfen Li, Kotomi Kawasaki, Katsuyuki Aozasa, Tadamitsu Kishimoto, Keiko Udaka, Haruo Sugiyama

Published in: Journal of Clinical Immunology | Issue 3/2000

Login to get access
Metadata
Title
Cytotoxic T-Lymphocyte Responses Elicited to Wilms' Tumor Gene WT1 Product by DNA Vaccination
Authors
Akihiro Tsuboi
Yoshihiro Oka
Hiroyasu Ogawa
Olga A. Elisseeva
Hanfen Li
Kotomi Kawasaki
Katsuyuki Aozasa
Tadamitsu Kishimoto
Keiko Udaka
Haruo Sugiyama
Publication date
01-05-2000
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Clinical Immunology / Issue 3/2000
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1023/A:1006637529995

Other articles of this Issue 3/2000

Journal of Clinical Immunology 3/2000 Go to the issue

OriginalPaper

Active Immunization of Humans with Dendritic Cells

OriginalPaper

Molecular Events of Bacterial-Induced Maturation ofDendritic Cells

OriginalPaper

Antigen-Specific Regulation of CD1 Expression in Humans

OriginalPaper

Elevation of IL-18 in Human Sepsis

OriginalPaper

Immune Response of SLE Patients to Peptides Based on the Complementarity Determining Regions of a Pathogenic Anti-DNA Monoclonal Antibody

OriginalPaper

Chemokines and Dendritic Cell Traffic
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits